NEXGEL to Report Third Quarter 2024 Financial Results on November 13th

NXGL 11.11.2024

SERA-AI Powered Highlights
Date of Upcoming Event:2024-11-13
Name of Upcoming Event:Earnings Call
Full Press ReleaseSEC FilingsOur NXGL Tweets

About Gravity Analytica

Recent News

  • 01.22.2025 - NEXGEL Issues Letter to Shareholders and Provides Guidance for 2024 and 2025
  • 01.02.2025 - NEXGEL Appoints Joseph F. McGuire as Chief Financial Officer
  • 11.21.2024 - NEXGEL to Participate in the iAccess Alpha Virtual Best Ideas Winter Conference on December 10-11, 2024

Recent Filings

  • 01.22.2025 - 8-K Current report
  • 01.22.2025 - EX-99.1 EX-99.1
  • 01.08.2025 - 4 Statement of changes in beneficial ownership of securities

NEXGEL to Report Third Quarter 2024 Financial Results on November 13th

November 11, 2024 9:00am ESTDownload as PDF

Management will host a conference call at 4:30 P.M. ET on the same day

LANGHORNE, Pa., Nov. 11, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced it will report its financial results for the third quarter 2024, after the market close on November 13, 2024. Following the release of its financial results, the Company will host a conference call at 4:30 P.M. ET on the same day.

Third Quarter 2024 Financial Results Conference CallDate:November 13, 2024Time:4:30 P.M. ETLive Call:1-800-225-9448 (U.S. Toll Free) or 1-203-518-9708 (International)Webcast:Events and Presentations

For interested individuals unable to join the conference call, a replay will be available through August 28, 2024 by dialing + 1-844-512-2921 (U.S. Toll Free) or + 1-412-317-6671 (International). Participants must use the following code to access the replay of the call: 11157563. An archived version of the webcast will also be available for 90 days.

About NEXGEL, INC.NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL brands include Silverseal®, Hexagels®, Turfguard®, Kenkoderm®and Silly George®. Additionally, NEXGEL has strategic contract manufacturing relationships with leading consumer healthcare companies.

Investor Contacts:Valter Pinto, Managing DirectorKCSA Strategic Communications212.896.1254Nexgel@KCSA.com

Primary Logo

Source: NEXGEL, INC.

Released November 11, 2024

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com